Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Vogler

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
Arthritis and Rheumatism|September 29, 2011
Hierarchy of risk of childhood-onset rheumatoid arthritis conferred by HLA-DRB1 alleles encoding the shared epitopeSampath Prahalad, Susan D Thompson, Karen N Conneely, et al.
Arthritis and Rheumatism|March 2, 2013
Susceptibility to childhood-onset rheumatoid arthritis: investigation of a weighted genetic risk score that integrates cumulative effects of variants at five genetic lociSampath Prahalad, Karen N Conneely, Yunxuan Jiang, et al.
Blood|January 3, 2001
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentationsA Villa, C Sobacchi, L D Notarangelo, et al.
Arthritis Care & Research|December 14, 2011
Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosusRina Mina, Emily von Scheven, Stacy P Ardoin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of TherapyClaas H Hinze, Dirk Foell, Anne L Johnson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2018
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive DiseaseDaniel J Lovell, Anne L Johnson, Bin Huang, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Arthritis and Rheumatism|September 29, 2011
Hierarchy of risk of childhood-onset rheumatoid arthritis conferred by HLA-DRB1 alleles encoding the shared epitopeSampath Prahalad, Susan D Thompson, Karen N Conneely, et al.
Arthritis and Rheumatism|March 2, 2013
Susceptibility to childhood-onset rheumatoid arthritis: investigation of a weighted genetic risk score that integrates cumulative effects of variants at five genetic lociSampath Prahalad, Karen N Conneely, Yunxuan Jiang, et al.
Blood|January 3, 2001
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentationsA Villa, C Sobacchi, L D Notarangelo, et al.
Arthritis Care & Research|December 14, 2011
Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosusRina Mina, Emily von Scheven, Stacy P Ardoin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of TherapyClaas H Hinze, Dirk Foell, Anne L Johnson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2018
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive DiseaseDaniel J Lovell, Anne L Johnson, Bin Huang, et al.
Pageof 13